Related Experiment Video
Updated: May 2, 2026

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes
Published on: March 25, 2014
An effective and effecient peptide binding prediction approach for a broad set of HLA-DR molecules based on ordered
Background:
The immune system must detect a wide variety of microbial pathogens, such as viruses, bacteria, fungi and parasitic worms, to protect the host against disease. Antigenic peptides displayed by MHC II (class II Major Histocompatibility Complex) molecules is a pivotal process to activate CD4+ TH cells (Helper T cells). The activated TH cells can differentiate into effector cells which assist various cells in activating against pathogen invasion. Each MHC locus encodes a great number of allele variants. Yet this limited number of MHC molecules are required to display enormous number of antigenic peptides. Since the peptide binding measurements of MHC molecules by biochemical experiments are expensive, only a few of the MHC molecules have suffecient measured peptides. To perform accurate binding prediction for those MHC alleles without suffecient measured peptides, a number of computational algorithms were proposed in the last decades.
Results:
Here, we propose a new MHC II binding prediction approach, OWA-PSSM, which is a significantly extended version of a well known method called TEPITOPE. The TEPITOPE method is able to perform prediction for only 50 MHC alleles, while OWA-PSSM is able to perform prediction for much more, up to 879 HLA-DR molecules. We evaluate the method on five benchmark datasets. The method is demonstrated to be the best one in identifying binding cores compared with several other popular state-of-the-art approaches. Meanwhile, the method performs comparably to the TEPITOPE and NetMHCIIpan2.0 approaches in identifying HLA-DR epitopes and ligands, and it performs significantly better than TEPITOPEpan in the identification of HLA-DR ligands and MultiRTA in identifying HLA-DR T cell epitopes.
Conclusions:
The proposed approach OWA-PSSM is fast and robust in identifying ligands, epitopes and binding cores for up to 879 MHC II molecules.
Insights
We developed OWA-PSSM, an improved MHC II binding prediction tool. It accurately identifies peptide ligands and epitopes for 879 HLA-DR molecules, outperforming other methods.
Area of Science:
- Immunology
- Computational Biology
- Bioinformatics
Background:
- The immune system identifies pathogens via Major Histocompatibility Complex (MHC) II molecules presenting antigenic peptides to CD4+ Helper T cells.
- Limited experimental data exists for many MHC II alleles due to costly peptide binding measurements.
- Accurate computational prediction of MHC II peptide binding is crucial for understanding immune responses.
Purpose of the Study:
- To introduce OWA-PSSM, an advanced computational approach for predicting MHC II molecule peptide binding.
- To extend the predictive capability for a larger number of MHC II alleles compared to existing methods.
Main Methods:
- OWA-PSSM is an extension of the TEPITOPE method, enhancing its predictive scope.
- The approach was evaluated on five benchmark datasets for performance assessment.
Main Results:
- OWA-PSSM accurately predicts binding cores, outperforming several state-of-the-art methods.
- It demonstrates comparable performance to TEPITOPE and NetMHCIIpan2.0 for HLA-DR epitopes and ligands.
- OWA-PSSM significantly outperforms TEPITOPEpan and MultiRTA in specific HLA-DR ligand and T cell epitope identification.
Conclusions:
- OWA-PSSM provides a fast and robust method for identifying ligands, epitopes, and binding cores for a wide range of MHC II molecules.
- The approach significantly expands the number of predictable HLA-DR molecules (up to 879).
More Related Videos
06:50Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions
Published on: January 26, 2024
09:32Immunopeptidomics: Isolation of Mouse and Human MHC Class I- and II-Associated Peptides for Mass Spectrometry Analysis
Published on: October 15, 2021
Related Concept Videos
Conserved Binding Sites
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
Protein-protein Interfaces
Ligand Binding Sites
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-Drug Binding: Determination Methods
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
The Equilibrium Binding Constant and Binding Strength